Improving glycemic control and cardiometabolic risk through integrated treatment plans.
Type 2 diabetes mellitus (T2DM) is associated with an increased risk of cardiovascular complications. This increased risk is present even before the diagnosis of diabetes is made. Therefore, it is imperative that physicians are aware of risk factors for diabetes and actively screen high-risk patients and diagnose the condition as early as possible. Patients with prediabetes must be counseled on interventions to prevent the progression to diabetes. Integrated treatment plans that address all aspects of disease must be implemented. Patients with diabetes should be examined for dyslipidemia, overweight or obesity, and hypertension. Treatment for patients with T2DM should include lifestyle interventions and should address any other comorbidities for which the patient may be at risk.
Lavernia
Frank
F
North Broward Diabetes Center in Pompano Beach, 4855 W Hillsboro Blvd, Suite B-6. Coconut Creek, FL 33073, USA. diabetescontrol@aol.com
D048909:Diabetes Complications / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D018450:Disease Progression; D006442:Glycated Hemoglobin / Q000032:analysis*; D038321:Glycemic Index; D006801:Humans; D006943:Hyperglycemia; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008019:Life Style; D008687:Metformin / Q000627:therapeutic use; D012307:Risk Factors; D040242:Risk Reduction Behavior
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D008687:Metformin